Victoria Most

Victoria Most is a consultant for computer-assisted ligand design at AFRY since February 2025. Previously, Victoria engaged in research as a Max Kade Fellowship Awardee at Vanderbilt University for three months in 2019, focusing on structural modeling of TCRpMHC complexes with non-canonical epitopes. Additionally, as a PhD graduate student at Universität Leipzig's Institute for Drug Discovery from May 2020 to March 2025, Victoria conducted doctoral research on T-cell therapy and the computational modeling and design of T-cell receptors-pMHC complexes. Victoria holds a Master of Science in Biochemistry from Universität Leipzig, completed in 2020.